CN1471514A - 用于治疗尿失禁的新颖间-氨基-苯亚氨基-咪唑烷衍生物 - Google Patents

用于治疗尿失禁的新颖间-氨基-苯亚氨基-咪唑烷衍生物 Download PDF

Info

Publication number
CN1471514A
CN1471514A CNA018170870A CN01817087A CN1471514A CN 1471514 A CN1471514 A CN 1471514A CN A018170870 A CNA018170870 A CN A018170870A CN 01817087 A CN01817087 A CN 01817087A CN 1471514 A CN1471514 A CN 1471514A
Authority
CN
China
Prior art keywords
expression
dimethylamino
benzene
bromo
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018170870A
Other languages
English (en)
Chinese (zh)
Inventor
I
弗朗兹·埃瑟
A��J�����Ｊ˹
帕斯卡尔·A·J·J·波泽特
喜多川久人
酒井兼司
村松郁延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of CN1471514A publication Critical patent/CN1471514A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA018170870A 2000-10-14 2001-10-11 用于治疗尿失禁的新颖间-氨基-苯亚氨基-咪唑烷衍生物 Pending CN1471514A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
DE10051005.1 2000-10-14

Publications (1)

Publication Number Publication Date
CN1471514A true CN1471514A (zh) 2004-01-28

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA018170870A Pending CN1471514A (zh) 2000-10-14 2001-10-11 用于治疗尿失禁的新颖间-氨基-苯亚氨基-咪唑烷衍生物

Country Status (23)

Country Link
EP (1) EP1328517A2 (de)
JP (1) JP2004511547A (de)
KR (1) KR20030046503A (de)
CN (1) CN1471514A (de)
AR (1) AR035923A1 (de)
AU (1) AU2002215943A1 (de)
BG (1) BG107711A (de)
BR (1) BR0114603A (de)
CA (1) CA2425563A1 (de)
CZ (1) CZ20031333A3 (de)
DE (1) DE10150312A1 (de)
EA (1) EA200300460A1 (de)
EC (1) ECSP034517A (de)
EE (1) EE200300177A (de)
HU (1) HUP0302245A3 (de)
IL (1) IL155338A0 (de)
MX (1) MXPA03003162A (de)
NO (1) NO20031697L (de)
PL (1) PL361359A1 (de)
SK (1) SK4342003A3 (de)
WO (1) WO2002032876A2 (de)
YU (1) YU28203A (de)
ZA (1) ZA200302345B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
AU2002215943A1 (en) 2002-04-29
PL361359A1 (en) 2004-10-04
EP1328517A2 (de) 2003-07-23
EA200300460A1 (ru) 2004-02-26
WO2002032876A2 (de) 2002-04-25
HUP0302245A2 (hu) 2003-10-28
NO20031697L (no) 2003-05-26
NO20031697D0 (no) 2003-04-11
YU28203A (sh) 2006-05-25
BG107711A (en) 2004-02-27
HUP0302245A3 (en) 2004-01-28
MXPA03003162A (es) 2004-12-06
IL155338A0 (en) 2003-11-23
DE10150312A1 (de) 2002-07-04
CZ20031333A3 (cs) 2003-08-13
JP2004511547A (ja) 2004-04-15
SK4342003A3 (en) 2003-10-07
WO2002032876A3 (de) 2002-07-18
ECSP034517A (es) 2003-04-25
BR0114603A (pt) 2003-10-14
AR035923A1 (es) 2004-07-28
CA2425563A1 (en) 2002-04-25
EE200300177A (et) 2003-08-15
KR20030046503A (ko) 2003-06-12
ZA200302345B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
CN101056862A (zh) 作为选择性雄激素受体调节剂（sarms）的新的咪唑烷－2－酮衍生物
CN1026322C (zh) 苯并哑唑衍生物的制备方法
CN1102596C (zh) 5H－噻唑并[3,2－a]嘧啶衍生物
CN1280266C (zh) 酰基苯基脲衍生物,其制备方法和作为药物的用途
CN1253551A (zh) 吡嗪化合物
CN1203895C (zh) 含前列腺素e1的局部组合物
CN1216049C (zh) 西酞普兰的制备方法
CN1106387C (zh) 抑制pdeiv的2－氰基亚氨基咪唑衍生物
JP2006510600A (ja) ２−チオヒダントインに由来する化合物及び治療におけるその使用
CN1558906A (zh) 嘧啶酮化合物及其药学上可接受的盐的制备方法
CN1197859C (zh) 常山碱和异常山碱及其制造方法
CN1019911C (zh) 新的苯并嗪衍生物的制备方法
EP0841330B1 (de) Aminomethylheterozyclischederivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CN1043527C (zh) 制备胍衍生物的方法
CN1471514A (zh) 用于治疗尿失禁的新颖间-氨基-苯亚氨基-咪唑烷衍生物
CN1860105A (zh) 制备6,7－二(2－甲氧基乙氧基)喹唑啉－4－酮的方法
CN1224609C (zh) 制备具有抗肥胖和抗糖尿病性质的芳基乙醇胺衍生物的方法
CN1042935C (zh) 2－氰基－3－羟基丙烯酰胺类化合物及其制法、用途和药物组合物
MMJ N-Substituted-3-chloro-2-azetidinones: Synthesis and characterization of new novel anti-inflammatory agents
CN86107151A (zh) 多巴胺-β-羟化酶抑制剂
CN100345848C (zh) 左旋卤代斯库利啉盐及其制备方法和用途
CN1046518C (zh) 新型的带杂环取代基的咪唑并喹喔啉酮及其制备方法和应用
CN1266057A (zh) 新的氰基－吲哚5－羟色胺再摄取抑制剂化合物、其制备方法和含有它们的药物组合物
CN1023223C (zh) 1，5-二苯基-1h-1，2，4-三唑-3-甲酰胺衍生物的制备方法
CN1040798A (zh) 苯并二氮杂草化合物及其制备方法和在药物上的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1060568

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1060568

Country of ref document: HK